Market Outlook
2 BIG New Features On Profitly: All-In-One Chatroom & Affiliatized Widgets [HOW TO VIDEO]
I am SO proud we got these features done…you should definitely check out the new all-in-one chatroom at http://profit.ly/profiding And earn 30% commissions by becoming a Profitly affiliate at http://profit.ly/affiliate and use the new widgets (existing widget users need …… .
Continue reading...(ITI, LIME, CVCO) PennyOmega.com Watch List for Friday Feb. 03, 2012
3 February 2012 – 12:23 am PST
ITI, Iteris, Inc. ** ITI reported financial results its third quarter fiscal 2012, posting net sales and contract revenues of $14.9 million, a 24% increase year over year, and net income totaled $0.7 million or $0.02 per share compared to a loss of $7.0 million or $(0.20) per share in the same period the [Read [...]
Continue reading...Discovery Labs Cleared to Market AFECTAIR in U.S.
3 February 2012 – 12:23 am PST
New, Proprietary Technology Simplifies Delivery of Aerosolized Medications to Patients Requiring Ventilatory Support WARRINGTON, PA, Feb. 2, 2012 (CRWENEWSWIRE) — Discovery Laboratories, Inc. (NASDAQ:DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced AFECTAIR(R) is now registered with the Food and Drug Administration (FDA) and is cleared [...]
Continue reading...Green Mountain Coffee Roasters, Inc. Reports Fiscal Year 2012 First Quarter Results
3 February 2012 – 12:23 am PST
Strong Keurig(R) Single Cup Brewer and Beverage Holiday Sales Drive 102% Net Sales Growth WATERBURY, VT — (CRWENEWSWIRE) — Green Mountain Coffee Roasters, Inc., (GMCR) (NASDAQ:GMCR), a leader in specialty coffee and coffee makers, today announced its fiscal year 2012 first quarter results for the thirteen weeks ended December 24, 2011. Performance Highlights First Quarter [...]
Continue reading...StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
3 February 2012 – 12:23 am PST
NEWARK, Calif., Feb. 2, 2012 (CRWENEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced that the U.S. Food and Drug Administration (FDA) has authorized the initiation of a Phase I/II clinical trial of the Company’s proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) in dry age-related macular degeneration (AMD), the most common form of AMD. [...]
Continue reading...(DSCO, STEM, GMCR) PennyOmega.com Stocks In Action
3 February 2012 – 12:23 am PST
STEM, StemCells, Inc. ** STEM reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company’s proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration (AMD), the most common form of AMD. AMD is the leading cause of vision loss and blindness in [Read [...]
Continue reading...CACI Reports Record Results for Its Fiscal 2012 Second Quarter and Raises Fiscal 2012 Guidance
3 February 2012 – 12:23 am PST
Pro forma diluted EPS increased 41.4 percent Pro forma net income increased 24.8 percent Pro forma operating income increased 26.8 percent Revenue increased 12.2 percent; organic revenue increased 8.9 percent ARLINGTON, VA – 02/01/2012 (CRWENEWSWIRE) — CACI International Inc (NYSE:CACI), a leading professional services and information technology solutions provider to the federal government, announced [...]
Continue reading...Athersys Announces Positive Results of MultiStem(R) Clinical Trial for Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease
3 February 2012 – 12:22 am PST
Trial Results Could Provide Basis for Accelerating Clinical Development of MultiStem(R) Orphan Drug Candidate CLEVELAND, Feb. 1, 2012 (CRWENEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) today announced positive results from its Phase I clinical trial of MultiStem(R), its cell therapy product, administered to individuals undergoing allogeneic hematopoietic stem cell transplants (HSCT) for the treatment of leukemia [...]
Continue reading...(ORN, MJGCF, ACAD, WMGI, LPNT) Notable Stock by PennyOmega.com
3 February 2012 – 12:22 am PST
Orion Marine Group, Inc. (NYSE:ORN), a leading heavy civil marine contractor serving the infrastructure sector, recently announced a contract award of approximately $12 million. Orion Marine Group was recently awarded a berth construction contract for the Canaveral Port Authority in Florida. Work consists of the construction of two ship docks and dredging at the site [...]
Continue reading...Orion Marine Group Announces a Contract Award of Approximately $12 Million
3 February 2012 – 12:22 am PST
HOUSTON, Feb. 1, 2012 (CRWENEWSWIRE) — Orion Marine Group, Inc. (NYSE:ORN) (the “Company”), a leading heavy civil marine contractor serving the infrastructure sector, today announced a contract award of approximately $12 million. Orion Marine Group was recently awarded a berth construction contract for the Canaveral Port Authority in Florida. Work consists of the construction [...]
Continue reading...
3 February 2012 – 12:23 am PST
View Comments